Jarrod Longcor is COO at Cellectar Biosciences, Inc. (CLRB). They have made 7 open-market trades across 1 company since 2018, most recently 2026-05-07.
CIK 0001545565
7 open-market purchases totalling $275K since 2018, never a sale. Across 7 scored buys the stock is down 5.6% at ninety days, and 9.1 points behind the S&P over the same stretch.
7 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| CLRB | 36,149 | $41K |
Shares reported on the most recent Form 4, priced at the 2026-05-11 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 57% | 43% | 43% |
| Avg Move | +1.2% | -5.2% | -5.6% |
| Alpha | +0.4% | -4.8% | -9.1% |
| Scored | 7 | 7 | 7 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CLRB | BUY | 2026-05-07 | 2026-05-11 | $2.88 | $25K | +7.6% | -23.6% | -13.0% |
| CLRB | BUY | 2025-07-02 | 2025-07-03 | $4.99 | $50K | +7.7% | +8.1% | +23.3% |
| CLRB | BUY | 2025-01-10 | 2025-03-12 | $0.28 | $8K | +22.1% | -12.6% | +14.5% |
| CLRB | BUY | 2020-12-28 | 2020-12-28 | $1.35 | $40K | -14.8% | -14.8% | -31.8% |
| CLRB | BUY | 2020-06-05 | 2020-06-08 | $1.15 | $150K | -10.4% | +14.2% | -20.9% |
| CLRB | BUY | 2019-02-28 | 2019-03-01 | $2.00 | $200 | +4.5% | +21.5% | +15.5% |
| CLRB | BUY | 2018-08-16 | 2018-08-17 | $2.71 | $1K | -8.6% | -29.3% | -26.8% |
| CLRB | SELL · 10b5-1 | 2018-03-13 | 2018-03-14 | $1.18 | $15K | -6.1% | +1.6% | -22.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.